244 related articles for article (PubMed ID: 36815984)
21. Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling.
Han W; Ma Q; Liu Y; Wu W; Tu Y; Huang L; Long Y; Wang W; Yee H; Wan Z; Tang R; Tang H; Wan Y
Phytomedicine; 2019 Apr; 57():203-214. PubMed ID: 30785016
[TBL] [Abstract][Full Text] [Related]
22. Geniposide alleviates diabetic nephropathy of mice through AMPK/SIRT1/NF-κB pathway.
Li F; Chen Y; Li Y; Huang M; Zhao W
Eur J Pharmacol; 2020 Nov; 886():173449. PubMed ID: 32758570
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of the glycogen synthase kinase 3β-hypoxia-inducible factor 1α pathway alleviates NLRP3-mediated pyroptosis induced by high glucose in renal tubular epithelial cells.
Wan J; Jiang Z; Liu D; Pan S; Zhou S; Liu Z
Exp Physiol; 2022 Dec; 107(12):1493-1506. PubMed ID: 36056793
[TBL] [Abstract][Full Text] [Related]
24. Fucoidan Alleviates Renal Fibrosis in Diabetic Kidney Disease
Wang MZ; Wang J; Cao DW; Tu Y; Liu BH; Yuan CC; Li H; Fang QJ; Chen JX; Fu Y; Wan BY; Wan ZY; Wan YG; Wu GW
Front Pharmacol; 2022; 13():790937. PubMed ID: 35370636
[No Abstract] [Full Text] [Related]
25. Zhen-wu-tang ameliorates membranous nephropathy rats through inhibiting NF-κB pathway and NLRP3 inflammasome.
Liu B; Lu R; Li H; Zhou Y; Zhang P; Bai L; Chen D; Chen J; Li J; Yu P; Wu J; Liang C; Song J; Liu X; Zhou J
Phytomedicine; 2019 Jun; 59():152913. PubMed ID: 30991182
[TBL] [Abstract][Full Text] [Related]
26. Rutaecarpine protects podocytes in diabetic kidney disease by targeting VEGFR2/NLRP3-mediated pyroptosis.
Hu X; Wang J; Jiang L; Liu X; Ge Q; Wang Q; Qi X; Wu Y
Int Immunopharmacol; 2024 Mar; 130():111790. PubMed ID: 38447417
[TBL] [Abstract][Full Text] [Related]
27. Astragaloside IV ameliorates diabetic nephropathy in
Feng H; Zhu X; Tang Y; Fu S; Kong B; Liu X
Int J Mol Med; 2021 Aug; 48(2):. PubMed ID: 34278447
[TBL] [Abstract][Full Text] [Related]
28. Carnosine alleviates podocyte injury in diabetic nephropathy by targeting caspase-1-mediated pyroptosis.
Zhu W; Li YY; Zeng HX; Liu XQ; Sun YT; Jiang L; Xia LL; Wu YG
Int Immunopharmacol; 2021 Dec; 101(Pt B):108236. PubMed ID: 34653727
[TBL] [Abstract][Full Text] [Related]
29. NLRP3 inflammasome negatively regulates podocyte autophagy in diabetic nephropathy.
Hou Y; Lin S; Qiu J; Sun W; Dong M; Xiang Y; Wang L; Du P
Biochem Biophys Res Commun; 2020 Jan; 521(3):791-798. PubMed ID: 31703838
[TBL] [Abstract][Full Text] [Related]
30. Syringaresinol protects against diabetic nephropathy by inhibiting pyroptosis via NRF2-mediated antioxidant pathway.
Li G; Liu C; Yang L; Feng L; Zhang S; An J; Li J; Gao Y; Pan Z; Xu Y; Liu J; Wang Y; Yan J; Cui J; Qi Z; Yang L
Cell Biol Toxicol; 2023 Jun; 39(3):621-639. PubMed ID: 36640193
[TBL] [Abstract][Full Text] [Related]
31. Integrated Network Pharmacology and Cellular Assay to Explore the Mechanisms of Selenized Tripterine Phytosomes (Se@Tri-PTs) Alleviating Podocyte Injury in Diabetic Nephropathy.
Zhu S; Liu Q; Chang Y; Luo C; Zhang X; Sun S
Curr Pharm Des; 2023; 29(38):3073-3086. PubMed ID: 37961864
[TBL] [Abstract][Full Text] [Related]
32. Klotho alleviates contrast-induced acute kidney injury by suppressing oxidative stress, inflammation, and NF-KappaB/NLRP3-mediated pyroptosis.
Fu Y; Cao J; Wei X; Ge Y; Su Z; Yu D
Int Immunopharmacol; 2023 May; 118():110105. PubMed ID: 37018977
[TBL] [Abstract][Full Text] [Related]
33. [Hepatitis B virus X protein promotes podocyte pyroptosis in hepatitis B virus-associated glomerulonephritis by down-regulating microRNA -223 targeting NLRP3 inflammasome].
Yu YN; Chen YQ; Li BS; Yang XQ; Feng MX; Jiang W
Zhonghua Gan Zang Bing Za Zhi; 2023 Jan; 39(1):20-31. PubMed ID: 36776011
[No Abstract] [Full Text] [Related]
34. Dapagliflozin prevents kidney podocytes pyroptosis via miR-155-5p/HO-1/NLRP3 axis modulation.
Zhang ZW; Tang MQ; Liu W; Song Y; Gao MJ; Ni P; Zhang DD; Mo QG; Zhao BQ
Int Immunopharmacol; 2024 Apr; 131():111785. PubMed ID: 38479158
[TBL] [Abstract][Full Text] [Related]
35. Cepharanthine and Piperine ameliorate diabetic nephropathy in rats: role of NF-κB and NLRP3 inflammasome.
Samra YA; Said HS; Elsherbiny NM; Liou GI; El-Shishtawy MM; Eissa LA
Life Sci; 2016 Jul; 157():187-199. PubMed ID: 27266851
[TBL] [Abstract][Full Text] [Related]
36. Alpha-kinase1 promotes tubular injury and interstitial inflammation in diabetic nephropathy by canonical pyroptosis pathway.
Cui X; Li Y; Yuan S; Huang Y; Chen X; Han Y; Liu Z; Li Z; Xiao Y; Wang Y; Sun L; Liu H; Zhu X
Biol Res; 2023 Feb; 56(1):5. PubMed ID: 36732854
[TBL] [Abstract][Full Text] [Related]
37. Knockdown of TLR4 attenuates high glucose-induced podocyte injury via the NALP3/ASC/Caspase-1 signaling pathway.
Liu Y; Xu Z; Ma F; Jia Y; Wang G
Biomed Pharmacother; 2018 Nov; 107():1393-1401. PubMed ID: 30257355
[TBL] [Abstract][Full Text] [Related]
38. GLP-1RAs inhibit the activation of the NLRP3 inflammasome signaling pathway to regulate mouse renal podocyte pyroptosis.
Li X; Jiang X; Jiang M; Wang ZF; Zhao T; Cao SM; Li QM
Acta Diabetol; 2024 Feb; 61(2):225-234. PubMed ID: 37847379
[TBL] [Abstract][Full Text] [Related]
39. [Triptolide inhibits NLRP3 inflammasome activation and ameliorates podocyte epithelial-mesenchymal transition induced by high glucose].
Wu W; Liu BH; Wan YG; Sun W; Liu YL; Wang WW; Fang QJ; Tu Y; Yee HY; Yuan CC; Wan ZY
Zhongguo Zhong Yao Za Zhi; 2019 Dec; 44(24):5457-5464. PubMed ID: 32237395
[TBL] [Abstract][Full Text] [Related]
40. Punicalagin Protects Diabetic Nephropathy by Inhibiting Pyroptosis Based on TXNIP/NLRP3 Pathway.
An X; Zhang Y; Cao Y; Chen J; Qin H; Yang L
Nutrients; 2020 May; 12(5):. PubMed ID: 32456088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
